Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Strain Differences in Mouse Models of Pentosan Polysulfate Retinopathy
Author Affiliations & Notes
  • Preston Elliott Girardot
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
    Atlanta VA Center for Visual & Neurocognitive Rehabilitation, Decatur, Georgia, United States
  • Xian Zhang
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
    Central South University, Changsha, Hunan, China
  • Nan Zhang
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
    Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
  • Kevin J Donaldson
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
    Neuroscience Institute, Georgia State University, Atlanta, Georgia, United States
  • Micah A Chrenek
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
  • Jana T Sellers
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
  • Andrew J. Feola
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
    Atlanta VA Center for Visual & Neurocognitive Rehabilitation, Decatur, Georgia, United States
  • John M Nickerson
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
  • Nieraj Jain
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
  • Jeffrey H Boatright
    Department of Ophthalmology, Emory University, Atlanta, Georgia, United States
    Atlanta VA Center for Visual & Neurocognitive Rehabilitation, Decatur, Georgia, United States
  • Footnotes
    Commercial Relationships   Preston Girardot None; Xian Zhang None; Nan Zhang None; Kevin Donaldson None; Micah Chrenek None; Jana Sellers None; Andrew Feola None; John Nickerson None; Nieraj Jain None; Jeffrey Boatright None
  • Footnotes
    Support  RPB Challenge Grant to Emory Ophthalmology, Foundation Fighting Blindness grant CD-C-0918-0748-EEC (NJ), NIH grants P30EY06360 (Atlanta Vision Research Community), R01EY028859 (JHB), R01EY021592 (JMN), R01EY028450 (JMN), Veterans Affairs Office of Rehabilitation Research and Development grants RX002806 and RX001924 (JHB), Rehab R&D Service Career Development Award RX002342 (AJF), and the Abraham J and Phyllis Katz Foundation (JHB)
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4651. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Preston Elliott Girardot, Xian Zhang, Nan Zhang, Kevin J Donaldson, Micah A Chrenek, Jana T Sellers, Andrew J. Feola, John M Nickerson, Nieraj Jain, Jeffrey H Boatright; Strain Differences in Mouse Models of Pentosan Polysulfate Retinopathy. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4651.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pentosan polysulfate sodium (PPS) is prescribed to treat bladder pain or discomfort associated with interstitial cystitis. Pearce et al. [2018] discovered that long term PPS use is associated with a maculopathy suggestive of retinal pigment epithelium (RPE) injury. We previously demonstrated that prolonged treatment with PPS causes retinal dysfunction and subtle changes to outer segment length and RPE cell morphology in the 129S2/SvPas mouse. Here we report and compare the effects of the drug on the more common C57BL/6 mouse strain.

Methods : 10 male and 10 female age-matched C57BL/6J mice were given ad libitum mouse chow, either standard or supplemented with PPS. The daily dosage of PPS was initially 500 mg/kg mouse weight, later increased to 1000 mg/kg, then finally 2000 mg/kg over 14 months. Mice regularly had retinal function assessed by electroretinography (ERG). Mice were sacrificed after being maintained for 7 months on the highest PPS dose and eyes were fixed for RPE flat-mounting. Flatmounts were stained with a-e-catenin and ZO-1 and imaged using confocal microscopy. Images were analyzed using a custom pipeline in CellProfiler.

Results : During the 7 months on the highest dose, we observed a main drug effect of reduced ERG c-wave amplitudes (p=0.02, 2-way ANOVA). We observed no significant difference in a- or b-wave amplitudes. Analysis of the RPE flatmounts showed subtle differences in RPE cell shape. RPE from PPS-treated mice had decreased mean cell solidity, form factor, and extent, as well as increased compactness (p<0.05, unpaired t-tests). RPE flatmount analysis also showed that treated mice had less a-e-catenin immunostaining at cell edges (p=0.04, unpaired t-test).

Conclusions : The C57BL/6J mouse seems to be more resistant to retinal effects of PPS treatment than 129S2/SvPas mice. The C57 phenotype may be reflective of earlier processes in the 129SV mice. For example, ERG c-wave amplitudes were reduced before a- and b-wave amplitudes in the 129SV while the only reductions we saw in the C57 mice were with c-waves. C57 mice had differences in RPE cell shape in common with the 129SV mice. C57 mice had changes in RPE a-e-catenin immunostaining, but they were decreases at the cell edges rather than increases in the intracellular space seen in 129SV mice. Future studies are aimed at discovering what accounts for these strain differences as that should be useful in determining the mechanism of drug toxicity.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×